Status:
TERMINATED
Bone Mineral Density (BMD) in HIV Infection
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Osteopenia
Osteoporosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Osteopenia and osteoporosis are increasingly reported in HIV-infected patients, and appear to be more frequent than in general population. However, pathogenesis remains unclear, and published studies ...
Eligibility Criteria
Inclusion
- HIV-1 infected men, Caucasian, age \> 18 years, ARV-naïve
Exclusion
- HIV-infected women, subjects \< 18 years, non-Caucasian men, ARV-experienced patients, subjects not able or willing to give informed consent, endocrine disease or treatment which could affect bone metabolism
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2006
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00146094
Start Date
March 1 2003
End Date
December 14 2006
Last Update
September 26 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Colmar
Colmar, France, 68021
2
Centre Hospitalier de Mulhouse
Mulhouse, France, 68070
3
Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091